Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2050707357', 'doi': 'https://doi.org/10.7326/0003-4819-143-8-200510180-00022', 'title': 'The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors', 'display_name': 'The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors', 'publication_year': 2005, 'publication_date': '2005-10-18', 'ids': {'openalex': 'https://openalex.org/W2050707357', 'doi': 'https://doi.org/10.7326/0003-4819-143-8-200510180-00022', 'mag': '2050707357', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16230737'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-143-8-200510180-00022', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5018746363', 'display_name': 'Ken Shinmura', 'orcid': 'https://orcid.org/0000-0002-1419-3574'}, 'institutions': [{'id': 'https://openalex.org/I142740786', 'display_name': 'University of Louisville', 'ror': 'https://ror.org/01ckdn478', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I142740786']}, {'id': 'https://openalex.org/I203951103', 'display_name': 'Keio University', 'ror': 'https://ror.org/02kn6nx58', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I203951103']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Ken Shinmura', 'raw_affiliation_strings': ['From Keio University School of Medicine, Tokyo, Japan, and Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292.'], 'affiliations': [{'raw_affiliation_string': 'From Keio University School of Medicine, Tokyo, Japan, and Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292.', 'institution_ids': ['https://openalex.org/I142740786', 'https://openalex.org/I203951103']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008671980', 'display_name': 'Roberto Bolli', 'orcid': 'https://orcid.org/0000-0002-9160-8614'}, 'institutions': [{'id': 'https://openalex.org/I142740786', 'display_name': 'University of Louisville', 'ror': 'https://ror.org/01ckdn478', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I142740786']}, {'id': 'https://openalex.org/I203951103', 'display_name': 'Keio University', 'ror': 'https://ror.org/02kn6nx58', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I203951103']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Roberto Bolli', 'raw_affiliation_strings': ['From Keio University School of Medicine, Tokyo, Japan, and Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292.'], 'affiliations': [{'raw_affiliation_string': 'From Keio University School of Medicine, Tokyo, Japan, and Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292.', 'institution_ids': ['https://openalex.org/I142740786', 'https://openalex.org/I203951103']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.58952, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 74, 'max': 76}, 'biblio': {'volume': '143', 'issue': '8', 'first_page': '617', 'last_page': '617'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10678', 'display_name': 'Cyclooxygenase-2 Inhibitors in Inflammation and Cancer', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10678', 'display_name': 'Cyclooxygenase-2 Inhibitors in Inflammation and Cancer', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy in Cardiovascular Disease', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13489', 'display_name': 'Synthesis and Applications of ß-Lactams', 'score': 0.9872, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/valdecoxib', 'display_name': 'Valdecoxib', 'score': 0.7416166}, {'id': 'https://openalex.org/keywords/cyclooxygenase-2-inhibitors', 'display_name': 'Cyclooxygenase-2 Inhibitors', 'score': 0.549722}, {'id': 'https://openalex.org/keywords/bleeding-risk', 'display_name': 'Bleeding Risk', 'score': 0.50973}, {'id': 'https://openalex.org/keywords/cardiovascular-risk', 'display_name': 'Cardiovascular Risk', 'score': 0.502442}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.914932}, {'id': 'https://openalex.org/C2778582115', 'wikidata': 'https://www.wikidata.org/wiki/Q411412', 'display_name': 'Rofecoxib', 'level': 4, 'score': 0.82418823}, {'id': 'https://openalex.org/C2781128415', 'wikidata': 'https://www.wikidata.org/wiki/Q412050', 'display_name': 'Prostacyclin', 'level': 2, 'score': 0.77488697}, {'id': 'https://openalex.org/C2779528491', 'wikidata': 'https://www.wikidata.org/wiki/Q347613', 'display_name': 'Valdecoxib', 'level': 5, 'score': 0.7416166}, {'id': 'https://openalex.org/C2779689624', 'wikidata': 'https://www.wikidata.org/wiki/Q410251', 'display_name': 'Cyclooxygenase', 'level': 3, 'score': 0.67330873}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.6723237}, {'id': 'https://openalex.org/C2777015399', 'wikidata': 'https://www.wikidata.org/wiki/Q4775337', 'display_name': 'Antithrombotic', 'level': 2, 'score': 0.6632458}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.6550749}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.48803678}, {'id': 'https://openalex.org/C2776785769', 'wikidata': 'https://www.wikidata.org/wiki/Q412212', 'display_name': 'Thromboxane', 'level': 3, 'score': 0.47986263}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.47959152}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.37159595}, {'id': 'https://openalex.org/C89560881', 'wikidata': 'https://www.wikidata.org/wiki/Q101026', 'display_name': 'Platelet', 'level': 2, 'score': 0.15569079}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D016861', 'descriptor_name': 'Cyclooxygenase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D009203', 'descriptor_name': 'Myocardial Infarction', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D011451', 'descriptor_name': 'Prostaglandin-Endoperoxide Synthases', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000893', 'descriptor_name': 'Anti-Inflammatory Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000893', 'descriptor_name': 'Anti-Inflammatory Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001241', 'descriptor_name': 'Aspirin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001241', 'descriptor_name': 'Aspirin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051546', 'descriptor_name': 'Cyclooxygenase 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D052246', 'descriptor_name': 'Cyclooxygenase 2 Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016861', 'descriptor_name': 'Cyclooxygenase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016861', 'descriptor_name': 'Cyclooxygenase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008565', 'descriptor_name': 'Membrane Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009203', 'descriptor_name': 'Myocardial Infarction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011451', 'descriptor_name': 'Prostaglandin-Endoperoxide Synthases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011451', 'descriptor_name': 'Prostaglandin-Endoperoxide Synthases', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012307', 'descriptor_name': 'Risk Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-143-8-200510180-00022', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16230737', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.65, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 6, 'referenced_works': ['https://openalex.org/W2020563114', 'https://openalex.org/W2047876380', 'https://openalex.org/W2070469088', 'https://openalex.org/W2080605373', 'https://openalex.org/W2082001748', 'https://openalex.org/W2139776244'], 'related_works': ['https://openalex.org/W2938903118', 'https://openalex.org/W2411896465', 'https://openalex.org/W2393019286', 'https://openalex.org/W2157438522', 'https://openalex.org/W2100421100', 'https://openalex.org/W2089485618', 'https://openalex.org/W2078544717', 'https://openalex.org/W2043600979', 'https://openalex.org/W2035858792', 'https://openalex.org/W1968818398'], 'abstract_inverted_index': {'Letters18': [0], 'October': [1, 538, 546, 551], '2005The': [2], 'Risk': [3, 429, 454, 473, 496], 'for': [4, 38, 66, 88, 232, 430, 455, 474, 497], 'Myocardial': [5, 431, 456, 475, 498], 'Infarction': [6, 432, 457, 476, 499], 'with': [7, 172, 235, 433, 458, 477, 500], 'Cyclooxygenase-2': [8, 320, 434, 459, 478, 501], 'InhibitorsKen': [9], 'Shinmura,': [10, 17, 398], 'MD,': [11, 18, 399], 'PhD': [12], 'and': [13, 27, 44, 55, 73, 111, 127, 154, 163, 272, 378, 394, 412, 450, 469, 491, 510, 526, 534], 'Roberto': [14, 45, 401], 'Bolli,': [15, 46, 402], 'MDKen': [16], 'PhDFrom': [19], 'Keio': [20, 48, 405], 'University': [21, 32, 49, 60, 406, 417], 'School': [22, 50, 407], 'of': [23, 29, 33, 51, 57, 61, 91, 161, 178, 182, 198, 206, 210, 241, 267, 325, 329, 362, 366, 383, 408, 414, 418, 439, 524, 561], 'Medicine,': [24, 52, 409], 'Tokyo,': [25, 53, 410], 'Japan,': [26, 54, 411], 'Institute': [28, 56, 413], 'Molecular': [30, 58, 415], 'Cardiology,': [31, 59, 416], 'Louisville,': [34, 35, 62, 63, 419, 420], 'KY': [36, 64, 421], '40292.Search': [37, 65], 'more': [39, 67], 'papers': [40, 68], 'by': [41, 69, 200, 558], 'this': [42, 70], 'author': [43], 'MDFrom': [47], 'authorAuthor,': [71], 'Article,': [72, 393], 'Disclosure': [74, 395], 'Informationhttps://doi.org/10.7326/0003-4819-143-8-200510180-00022': [75], 'SectionsAboutFull': [76], 'TextPDF': [77], 'ToolsAdd': [78], 'to': [79, 94, 296], 'favoritesDownload': [80], 'CitationsTrack': [81], 'CitationsPermissions': [82], 'ShareFacebookTwitterLinkedInRedditEmail': [83], 'TO': [84], 'THE': [85], 'EDITOR:The': [86], 'reason': [87], 'the': [89, 159, 203, 268, 291, 322, 326, 380], 'propensity': [90], 'COX-2': [92, 120, 269, 369], 'inhibitors': [93, 270], 'facilitate': [95], 'cardiovascular': [96, 135, 174], 'events': [97, 175], 'remains': [98], 'unclear.': [99], 'A': [100, 436], 'commonly': [101], 'postulated': [102], 'mechanism': [103], 'is': [104, 370], 'an': [105], 'imbalance': [106], 'between': [107], 'prostacyclin': [108, 116, 199], '(antithrombotic': [109], 'activity)': [110, 114], 'thromboxane': [112], '(prothrombotic': [113], 'because': [115], 'production': [117], 'depends': [118], 'on': [119, 518], 'activity': [121], 'in': [122, 137, 142, 147, 332], 'humans': [123], '(1).': [124], 'However,': [125], 'Lévesque': [126, 224, 444, 467], 'colleagues': [128, 155], '(2)': [129], 'reported': [130], 'that': [131, 158, 374], 'low-dose': [132, 179], 'aspirin': [133], 'mitigates': [134], 'risk': [136, 231], 'elderly': [138, 242], 'patients': [139], 'taking': [140, 149], 'rofecoxib': [141], 'low': [143], 'doses': [144], 'but': [145], 'not': [146], 'those': [148], 'high': [150], 'doses.': [151], 'Similarly,': [152], 'Nussmeier': [153, 252], '(3)': [156], 'demonstrated': [157], 'use': [160], 'parecoxib': [162, 271], 'valdecoxib': [164, 273], 'after': [165, 274], 'coronary': [166], 'artery': [167], 'bypass': [168], 'grafting': [169], 'was': [170], 'associated': [171], 'increased': [173], 'despite': [176], 'coadministration': [177], 'aspirin.': [180], 'Coadministration': [181], '...References1.': [183], 'McAdam': [184], 'BF,': [185], 'Catella-Lawson': [186], 'F,': [187], 'Mardini': [188], 'IA,': [189], 'Kapoor': [190], 'S,': [191], 'Lawson': [192], 'JA,': [193], 'FitzGerald': [194], 'GA.': [195], 'Systemic': [196], 'biosynthesis': [197], 'cyclooxygenase': [201, 367], '(COX)-2:': [202, 368], 'human': [204], 'pharmacology': [205], 'a': [207, 238, 363, 371], 'selective': [208], 'inhibitor': [209], 'COX-2.': [211], 'Proc': [212, 335], 'Natl': [213, 336], 'Acad': [214, 337], 'Sci': [215, 338], 'U': [216, 339], 'S': [217, 340], 'A.': [218, 341, 481], '1999;96:272-7.': [219], '[PMID:': [220, 248, 282, 302, 343, 388], '9874808]': [221], 'CrossrefMedlineGoogle': [222, 284, 304, 345, 390], 'Scholar2.': [223], 'LE,': [225], 'Brophy': [226, 448, 463], 'JM,': [227], 'Zhang': [228, 452, 471], 'B.': [229], 'The': [230, 453, 472, 495], 'myocardial': [233], 'infarction': [234], 'cyclooxygenase-2': [236], 'inhibitors:': [237], 'population': [239], 'study': [240], 'adults.': [243], 'Ann': [244], 'Intern': [245], 'Med.': [246, 280], '2005;142:481-9.': [247], '15809459]': [249], 'LinkGoogle': [250], 'Scholar3.': [251], 'NA,': [253], 'Whelton': [254], 'AA,': [255], 'Brown': [256], 'MT,': [257], 'Langford': [258], 'RM,': [259], 'Hoeft': [260], 'A,': [261], 'Parlow': [262], 'JL,': [263], 'et': [264, 318, 359], 'al.': [265, 319, 360], 'Complications': [266], 'cardiac': [275], 'surgery.': [276], 'N': [277], 'Engl': [278], 'J': [279], '2005;352:1081-91.': [281], '15713945]': [283], 'Scholar4.': [285], 'Yellon': [286], 'DM,': [287], 'Downey': [288], 'JM.': [289], 'Preconditioning': [290], 'myocardium:': [292], 'from': [293], 'cellular': [294], 'physiology': [295], 'clinical': [297, 529], 'cardiology.': [298], 'Physiol': [299], 'Rev.': [300], '2003;83:1113-51.': [301], '14506302]': [303], 'Scholar5.': [305], 'Shinmura': [306, 349], 'K,': [307, 350], 'Tang': [308, 351], 'XL,': [309, 352], 'Wang': [310], 'Y,': [311, 358], 'Xuan': [312, 355], 'YT,': [313, 356], 'Liu': [314], 'SQ,': [315], 'Takano': [316], 'H,': [317], 'mediates': [321, 379], 'cardioprotective': [323, 372], 'effects': [324], 'late': [327, 381, 522], 'phase': [328, 382, 523], 'ischemic': [330], 'preconditioning': [331, 525], 'conscious': [333], 'rabbits.': [334], '2000;97:10197-202.': [342], '10963682]': [344], 'Scholar6.': [346], 'Bolli': [347], 'R,': [348], 'Kodani': [353], 'E,': [354], 'Guo': [357], 'Discovery': [361], 'new': [364], 'function': [365], 'protein': [373], 'alleviates': [375], 'ischemia/reperfusion': [376], 'injury': [377], 'preconditioning.': [384], 'Cardiovasc': [385], 'Res.': [386], '2002;55:506-19.': [387], '12160947]': [389], 'Scholar': [391], 'Author,': [392], 'InformationAuthors:': [396], 'Ken': [397], 'PhD;': [400], 'MDAffiliations:': [403], 'From': [404], '40292.Disclosures:': [422], 'None': [423], 'disclosed.': [424], 'PreviousarticleNextarticle': [425], 'Advertisement': [426], 'FiguresReferencesRelatedDetailsSee': [427], 'AlsoThe': [428], 'Inhibitors:': [435], 'Population': [437], 'Study': [438], 'Elderly': [440], 'Adults': [441], 'Linda': [442, 465], 'E.': [443, 466], ',': [445, 449, 464, 468, 483, 487, 490, 506, 509], 'James': [446, 461], 'M.': [447, 462], 'Bin': [451, 470], 'Inhibitors': [460, 479, 502], 'Jeong': [480], 'Kim': [482], 'Youn': [484], 'Seon': [485], 'Choi': [486], 'Dokyung': [488], 'Yoon': [489], 'Kyung': [492], 'Hwan': [493], 'Cho': [494], 'Michal': [503], 'R.': [504], 'Pijak': [505], 'Igor': [507], 'Huzicka': [508], 'Frantisek': [511], 'Gazdik': [512], 'Metrics': [513], 'Cited': [514], 'byOccult': [515], 'Cardiotoxicity—Toxic': [516], 'Effects': [517], 'Cardiac': [519], 'Ischemic': [520], 'ToleranceThe': [521], 'its': [527], 'natural': [528], 'application—gene': [530], 'therapyCurrent': [531], 'awareness:': [532], 'Pharmacoepidemiology': [533], 'drug': [535], 'safety': [536], '18': [537, 545, 550], '2005Volume': [539], '143,': [540], 'Issue': [541, 548], '8Page:': [542], '617KeywordsDrugsHeartIschemiaMyocardiumProstacyclinProstaglandinProstaglandinsThromboxane': [543], 'ePublished:': [544], '2005': [547, 552, 557], 'Published:': [549], 'Copyright': [553], '&': [554], 'PermissionsCopyright': [555], '©': [556], 'American': [559], 'College': [560], 'Physicians.': [562], 'All': [563], 'Rights': [564], 'Reserved.PDF': [565], 'downloadLoading': [566], '...': [567]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2050707357', 'counts_by_year': [], 'updated_date': '2024-09-19T11:23:55.797183', 'created_date': '2016-06-24'}